These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21697023)

  • 1. [Fasting hyperglycaemia and polymorphism in glucokinase promoter (rs1799884)].
    Bahíllo Curieses P; Hermoso López F; Garrote Molpeceres R; Zurita Muñoz O; Campos Barros A
    An Pediatr (Barc); 2011 Oct; 75(4):273-6. PubMed ID: 21697023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.
    Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P
    Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes.
    Santos IC; Frigeri HR; Réa RR; Almeida AC; Souza EM; Pedrosa FO; Fadel-Picheth CM; Picheth G
    Clin Chim Acta; 2010 Jun; 411(11-12):892-3. PubMed ID: 20227404
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
    Massa O; Meschi F; Cuesta-Munoz A; Caumo A; Cerutti F; Toni S; Cherubini V; Guazzarotti L; Sulli N; Matschinsky FM; Lorini R; Iafusco D; Barbetti F;
    Diabetologia; 2001 Jul; 44(7):898-905. PubMed ID: 11508276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MODY diabetes--a monogenic developmental and functional disturbance of pancreatic beta cells].
    Miettinen PJ; Tuomi T
    Duodecim; 2012; 128(19):1989-98. PubMed ID: 23155750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.
    Rubio-Cabezas O; Díaz González F; Aragonés A; Argente J; Campos-Barros A
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):245-9. PubMed ID: 18298419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
    Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
    Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.
    Codner E; Rocha A; Deng L; Martínez-Aguayo A; Godoy C; Mericq V; Chung WK
    Pediatr Diabetes; 2009 Sep; 10(6):382-8. PubMed ID: 19309449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mature onset diabetes of the young (MODY)].
    Nobre EL; Lopes LO; Miranda A; Pragosa M; de Castro JJ
    Acta Med Port; 2002; 15(6):435-9. PubMed ID: 12680290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses.
    Weedon MN; Clark VJ; Qian Y; Ben-Shlomo Y; Timpson N; Ebrahim S; Lawlor DA; Pembrey ME; Ring S; Wilkin TJ; Voss LD; Jeffery AN; Metcalf B; Ferrucci L; Corsi AM; Murray A; Melzer D; Knight B; Shields B; Smith GD; Hattersley AT; Di Rienzo A; Frayling TM
    Am J Hum Genet; 2006 Dec; 79(6):991-1001. PubMed ID: 17186458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
    Lopez AP; Foscaldi SA; Pérez MS; Krochik G; Rodríguez M; Traversa M; Puchulu FM; Hirschler V; Bergada I; Frechtel GD
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):391-4. PubMed ID: 19358091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations.
    Singh R; Pearson ER; Clark PM; Hattersley AT
    Diabetologia; 2007 Mar; 50(3):620-4. PubMed ID: 17216282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).
    Shehadeh N; Bakri D; Njølstad PR; Gershoni-Baruch R
    Diabet Med; 2005 Aug; 22(8):994-8. PubMed ID: 16026363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.